Thank you Scott Eggener for visiting with us Moffitt Cancer Center! Great talks on GG1 prostate histology, surgeon's burnout and navigating challenging cases discussions.

Congrats to our 2025 match class! Looking forward to working with you!!@kendrick_yim David Nusbaum Renzo G. DiNatale Moffitt Cancer Center

It’s a privilege to work alongside the USF Urology residents who rotate at Moffitt Cancer Center. Thank you for the honor of being named TOTY, especially when there are so many deserving faculty.

⚡️ Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration #BladderCancer

Types of urology papers, I can’t stop laughing 😂…

New clinical fellows working hard! Josh Linscott Mitch Hayes

GU medical oncology faculty members Jad Chahoud and Jingsong Zhang showcasing research opportunities to our incoming Moffitt Cancer Center Medical Oncology fellows in today's Meet & Greet session. Welcome aboard!

Don't miss this year's Theodore F. Classen Memorial Lecture at the ACA in September! Not yet registered? Take advantage of early bird rates and register now! facos.org/acaregister #ACA2024 #ACOSMissionPossible

😂 #Urology

Twitter/X vs reality. Hope your Mondaying is going well, and that this puts a smile on your face. #pcsm #roboticprostatectomy

Urologist Michael Poch, MD (@Michael_Poch) shares insights on an innovative trial exploring TIL therapy for bladder cancer. This study is pushing boundaries and applying #TILtherapy to a new type of cancer. Read more: bit.ly/3Xfq3pA #CancerResearch

Not only a great surgeon & the YUO Moffitt Urologic Oncology Fellowship fellowship director, but an innovative researcher. Congrats on your TIL therapy trial Dr Michael Poch.

Bladder cancer session #JSMO25 - Longer term follow up for EVP showing 34 months median OS and 2 year median duration of response. Adverse events different from standard chemotherapy ウロミーゴズ

Couldn’t agree more. Leilei Xia found similar results in updated cohort 2010-2018 cT1 + LVI compared to T2 w/o LVI associated with significantly worse OS HR 1.63. Penn Urology Trinity J. Bivalacqua

Welcome to the Moffitt Cancer Center family! The future is bright! YUO Society of Urologic Oncology Amer. Urol. Assn. MUSC Urology Residency Yale Urology Georgetown University Urology

A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgical excellence was only matched by his devotion to pt care and teaching. Simply the best mentor, colleague and friend RIP Boss Society of Urologic Oncology Amer. Urol. Assn.

🎉 The Amer. Urol. Assn. and the UCF are excited to recognize 12 researchers as recipients of the 2025 Urology Care Foundation Research Scholar Awards! This program has invested over $30 million to support over 675 Research Scholars! Click to learn more 👉 bit.ly/48G1Iyn

🚨Publication alert in Urologic Oncology! National complication and cost burden of transurethral resection of bladder tumor for bladder cancer Click to read the article▶️ bit.ly/3JmhHt7

Proud of our USF Urology stars — Dr. Joe Balbona, Dr. Alyssa Biollota & Dr. Tyler Cook — finishing their Moffitt Cancer Center rotation! Until next time — the future of urology is in great hands. 👏 Amer. Urol. Assn. Urology Match

#RoboUroOnc City of Hope Surgery #Urology fellow, Dr. Ahmad Saeed Imam, Imam, presenting multidisciplinary research efforts at #WSAUA25 Western Section AUA in #prostatecancer & #ilealureter creation. Salvador Jaime-Casas, MD Bertram Yuh Wesley Yip Alex Chehrazi-Raffle, MD Sumanta K. Pal, MD, FASCO Kevin Chan, MD Clayton Lau